Biotech receives negative trend vote By: MarketMinute.com Stock News April 21, 2017 at 19:13 PM EDT The European Medicines Agency issued a negative "trend" vote for Biotech Inc.'s (Nasdaq: XBIT) marketing authorization application for its candidate antibody for the treatment of colorectal cancer. The stock price plunged $6.79 to close at $10.23. Related Stocks: Xbiotech Inc